XILITY
Live / Applied — First extension granted (statement of use) (as of 08 Oct 2025)
What this means for you
Not registered yet, but its 23 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98661992
- Mark type
- Stylized text
- Filed
- 23 Jul 2024
- Published for opposition
- 25 Feb 2025
- Attorney of record
- Mona Gupta
Goods and services
- Class 005 — Pharmaceuticals: In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for genetic testing; chemical reagents, preparations and test kits for nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with dna sequencing and genetic analysis
- Class 010 — Medical apparatus: Clinical or medical diagnostic apparatus and instruments, namely, nucleic acid sequencers, imaging devices and analyzers; medical diagnostic apparatus and instruments for the amplification and analysis of nucleic acids and the preparation of nucleic acid libraries sold together in the form of kit; medical equipment, namely, devices for analyzing nucleic acids and for dna sequencing for the purpose of rendering medical treatment and diagnosis, and downloadable software for use therewith sold as a unit
Owner
- Roche Molecular Systems, Inc., Pleasanton, CA, US
- Roche Molecular Systems, Inc., Pleasanton, CA, US
Prosecution history
- 09 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2025 — SOU EXTENSION 1 GRANTED
- 08 Oct 2025 — SOU EXTENSION 1 FILED
- 08 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Feb 2025 — PUBLISHED FOR OPPOSITION
- 19 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Feb 2025 — NON-FINAL ACTION E-MAILED
- 03 Feb 2025 — NON-FINAL ACTION WRITTEN